Graves' Orbitopathy
Graves’ orbitopathy is a disease that affects the eyes of people with Graves’ disease, an autoimmune disorder that can cause hyperthyroidism. Symptoms include bulging eyes, excessive tearing, eye pain, puffy eyes, the sensation of a foreign object in the eyes, and vision abnormalities.
Quick Answer
What it is
Graves’ orbitopathy is a disease that affects the eyes of people with Graves’ disease, an autoimmune disorder that can cause hyperthyroidism. Symptoms include bulging eyes, excessive tearing, eye pain, puffy eyes, the sensation of a foreign object in the eyes, and vision abnormalities.
Key findings
No graded findings are available yet.
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Graves' Orbitopathy
- Supplements Studied:0
Evidence-Based Protocol
Supplement stack ranked by research quality
Primary Stack (Tier 1)
Antioxidant; reduces orbital inflammation; improves quality of life in mild GO
Supporting Stack (Tier 2)
Immune modulation; deficiency associated with autoimmune thyroid disease
Anti-inflammatory; may support ocular surface health
Reduces oxidative stress in orbital tissues
How It Works
Graves' Orbitopathy (GO), also called Thyroid Eye Disease (TED), is an autoimmune condition affecting the muscles and tissues around the eyes. It usually occurs with Graves' disease (hyperthyroidism) but can occur before or after thyroid problems.
SYMPTOMS:
DISEASE PHASES:
RISK FACTORS:
CRITICAL: GO requires ophthalmological management. This protocol is SUPPORTIVE ONLY.
MEDICAL TREATMENTS:
MOST IMPORTANT:
* Selenium has strong evidence for mild GO (EUGOGO trial).
* Vitamin D supports immune modulation.
* Antioxidants may help reduce oxidative stress.
Expected timeline: Active phase typically lasts 12-24 months. Selenium shown to improve quality of life within 6 months in mild disease.